scholarly journals Obesity is correlated with poor outcome after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia

2020 ◽  
Vol 50 (8) ◽  
pp. 889-896
Author(s):  
Jian Yu ◽  
Shangnao Lin ◽  
Yi Luo ◽  
Jimin Shi ◽  
Yamin Tan ◽  
...  

Abstract Objective The relationship between body mass index and overall survival has been controversial in patients who suffered from hematological malignancies and underwent hematopoietic stem cell transplantation. Methods We collected the data of 686 acute leukemia patients who received only one allogeneic hematopoietic stem cell transplantation in our center from 2008 to 2017. Patients were divided into four groups (underweight, normal weight, overweight and obesity) according to their body mass index pre-hematopoietic stem cell transplantation. Results 56.4% of patients had normal body mass indices, 17.3% were underweight, 20.4% were overweight and 5.8% were with obesity. Concerning long-term follow-up, the probability of overall survival was significantly lower in overweight (P = 0.010) and patients with obesity (P = 0.065) as compared with normal weight patients, and no statistically significant difference between underweight and normal weight individuals (P = 0.810). The results demonstrated that higher body mass index was associated with poorer overall survival (hazard ratio: 1.79; 95% confidence interval: 1.33–2.40, P < 0.001) and shorter leukemia-free survival (hazard ratio: 1.78; 95% confidence interval: 1.35–2.34, P < 0.001). Additionally, patients exhibiting a higher body mass index were more likely to face the problem of relapse (30.6 vs 20.9%, P < 0.001). Furthermore, non-relapse mortality of patients with obesity was statistically higher than normal weight patients (22.5 vs 9.6%, P = 0.027). Besides, individuals with a higher abdominal girth had shorter survival (hazard ratio: 1.73; 95% confidence interval: 1.29–2.31, P < 0.001) and higher relapse rate (hazard ratio: 1.78; 95% confidence interval: 1.29–2.45, P = 0.001) as compared with those with a lower abdominal girth. Conclusion Our results indicate that obesity at pre-hematopoietic stem cell transplantation stage, whether characterized by higher body mass index or abdominal girth, is correlated with poorer outcome.

2019 ◽  
Vol 55 (6) ◽  
pp. 1175-1177
Author(s):  
Justin Tai ◽  
Matthew Buras ◽  
Jose Leis ◽  
Pierre Noel ◽  
Jeanne Palmer ◽  
...  

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e18004-e18004
Author(s):  
Sherilyn Alvaran Tuazon ◽  
Neil David Palmisiano ◽  
Scott W. Keith ◽  
Irina Kakhniashvili ◽  
Joanne E. Filicko-O'Hara

Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 5510-5510 ◽  
Author(s):  
Shengli Xue ◽  
Jing Yang ◽  
Xiang Zhang ◽  
Yueping Shen ◽  
Wu Depei

Abstract AIM: The present study was performed to investigate the association between body mass index (BMI) before transplantation and the overall survival (OS) of patients with allogeneic hematopoietic stem cell transplantation (allo-HSCT). METHODS: Data from 310 adults who were diagnosed with acute leukemia and underwent allo-HSCT between March 2001 and December 2011 were analyzed. Demographic and clinical data were collected from medical records. In accordance with the suggested BMI categories for Asian population, patients with BMIs of ≥23 and ≥25 kg/m2 were identified as overweight and obese, respectively. Hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated using Cox proportional hazards models, which were adjusted for possible confounding factors. RESULTS: The median follow-up time among the patients was 19.7 months (interquartile range = 8.1 to 37.7). A total of 93 (34.8%) patients died within the follow-up period. After adjusted for the potential confounders, normal-weight, overweight, and obese patients showed significantly lower HRs than underweight patients, with a significant trend of OS improvement upon increasing BMI (P = 0.019). Overweight and obese patients survived longer, with a significantly decreased HR by approximately 40% (HR = 0.60;95% CI: 0.38 to 0.95) compared with underweight and normal-weight patients. CONCLUSIONS: An increased OS was seen in allo-HSCT patients with BMI≥23 compared to those with lower BMI. Further studies are required to obtain better understanding of the effects of BMI or body composition on the survival of allo-HSCT patients. Disclosures No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document